TARSONS PRODUCTS LIMITED IPO – Nov 15 to 17

EspressoLogy

TARSONS PRODUCTS LIMITED IPO – Nov 15 to 17

November 12, 2021
TARSONS PRODUCTS LIMITED IPO – Nov 15 to 17

Tarsons Products Limited IPO is coming out with a fresh public issue to raise Rs 1024 crores from the market.

Key details of the issue:

  • Issue opens – Nov 15 (Monday)
  • Issue closes – Nov 17 (Wednesday)
  • Issue size – Rs 1024 crores
  • Price band – Rs 635 to 662 per equity share
  • Bid lot – 22 shares and in multiples thereof
  • Employee reservation – Equity shares aggregating up to Rs 60000
  • Employee discount – Rs 61 per share

And here are some details of the company and further details on the TARSONS PRODUCTS LIMITED IPO

Company details:

·        Tarsons Products Limited is an Indian labware company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (“CROs”), Diagnostic companies and hospitals (Source: Frost & Sullivan Report).

·        They manufacture a range of quality labware products which helps advance scientific discovery and improve healthcare (Source: Frost & Sullivan Report). As of June 30, 2021 they had a diversified product portfolio with over 1,700 SKUs across 300 products. Their product portfolio is classified into three key categories which include consumables, reusables, and others. ‘Consumables’ category includes products such as centrifuge ware, cryogenic ware, liquid handling, PCR consumables and petri dish, transfer pipettes and others. ‘Reusables’ category includes products such as bottles, carboys, beakers, measuring cylinders and tube racks. ‘Others’ category includes benchtop instrumentation such as vortex shakers, centrifuges pipettors and others.

·        They cater to a diverse range of end customers across various sectors which include research organizations, academic institutions, pharmaceutical companies, CROs, diagnostic companies, and hospitals. Some of their end customers include customers such as Indian Institute of Chemical Technology, National Centre for Biological Sciences across academic institutes and research organizations; Dr Reddy's Laboratories, Enzene Biosciences across pharmaceutical sectors; Syngene International, Veeda Clinical Research across CROs; and Molbio Diagnostics, Agappe Diagnostic, Metropolis Healthcare, Dr. Lal Path Labs, Mylab Life Solutions across other sectors such as diagnostics. They distribute their products to these end customers on a pan-India basis through their authorised distributors.

·        They currently operate through their five manufacturing facilities located in West Bengal. They believe that, with over 36 years of experience in life sciences, they have successfully built ‘Tarsons’ into a leading Indian company in terms of revenue in the plastic labware market in India (Source: Frost & Sullivan Report) and gained expertise in the production of a wide range of labware products. They supply products to life sciences industry under their brand label “TARSONS WITH THE WORDS -TRUST DELIVEREDTM”.

Issue size: Rs 1024 crores


Employee reservation: Equity shares aggregating up to Rs 60000


Employee discount: Rs 61 per share


Issue break-up:

  • QIB – 50% of the net offer – Rs 510 crores
  • NIB – 15% of the net offer – Rs 153 crores
  • RET – 35% of the net offer – Rs 357 crores

Listing: NSE and BSE

Registrar: KFin Technologies Private Limited

UPI: All retail applications through brokers are compulsorily in UPI mode

Not an Espresso customer, but still want to apply for the Latent View Analytics Ltd. IPO? Become an Espresso customer in just 15 mins* by tapping here and take it from there! (* T&C apply)

Team Espresso
by Team Espresso

We care that you succeed

Bringing readers the latest happenings from the world of Trading and Investments specifically and Finance in general.